Associations between fibrin d-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men

• Autores: S. Goya Wannamethee, Peter H. Whincup, Lucy Lennon, Olia Papacosta, Gordon D. Lowe
• Localización: Journal of the American Geriatrics Society, ISSN 0002-8614, Vol. 62, Nº. 12, 2014, págs. 2357-2362
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Objectives: To examine the independent relationships between fibrin D-dimer, interleukin 6 (IL-6), C-reactive protein (CRP), and fibrinogen and incident mobility limitation and mortality.

    Design: Prospective.

    Setting: General practice in 24 British towns.

    Participants: Men aged 60 to 79 without prevalent heart failure followed up for an average of 11.5 years (N = 3,925).

    Measurements: All-cause mortality (n = 1,286) and self-reported mobility disability obtained at examination in 1998 to 2000 and in a postal questionnaire 3 to 5 years later in 2003.

    Results: High D-dimer (top vs lowest tertile: adjusted odds ratio (aOR) = 1.46, 95% confidence interval = 1.02–2.05) and IL-6 (aOR = 1.43, 95% CI = 1.01–2.02) levels (but not CRP or fibrinogen) were associated with greater incident mobility limitation after adjustment for confounders and prevalent disease status. IL-6, CRP, fibrinogen, and D-dimer were significantly associated with total mortality after adjustment for confounders. Only D-dimer and IL-6 predicted total mortality independent of each other and the other biomarkers. The adjusted hazard ratio (aHR) was 1.16 (95% CI = 1.10–1.22) for a standard deviation increase in log D-dimer and 1.10 (95% CI = 1.04–1.18) for a standard deviation increase in log IL-6. D-dimer was independently related to vascular and nonvascular mortality, and IL-6 was independently related to vascular mortality. Risks of mobility limitation and mortality were greatest in those with a combination of high D-dimer and IL-6 levels.

    Conclusion: D-dimer and IL-6 are associated with risk of mobility limitation and mortality in older men without heart failure. The findings suggest that coagulation leads to functional decline and mortality s that inflammation does not explain.